Basal cell carcinoma
Exam relevance: in 11 of more than 50 board exam reports · rank 7
- Synonyms
- BCC, Basaliom, Basalzellkarzinom, rodent ulcer, non-melanoma skin cancer
- Specialty
- Dermatology · Skin tumours
- Images
- Clinical 3 · Dermoscopy 1 · Histology 6
- In the app
- 17 flashcards
- Last updated
- 10/2026 · Dr. Pascal Bafteh
Contents
Images (10)



Dermoscopy
Histology
Histology
Histology
Histology
Histology
HistologyDefinition
Basal cell carcinoma (BCC, basalioma, also called rodent ulcer) is a common, locally invasive keratinocyte cancer and the most common form of skin cancer. Patients often develop multiple primary tumours over time.
Basal cell carcinoma Origin: follicular/perifollicular pluripotent stem cells, Mutation of PTCH1/SMO in the Hedgehog signaling pathway or p53.
- Incidence: in Germany at least 200/100,000 population/year, semi-malignant, metastasis 0.0028–0.55%.
- Special form: Pinkus tumor (Fibroepithelioma).
Aetiopathogenesis
Risk Factors
General Risk Factors
- Further RF: Albinism, Xeroderma pigmentosum.
Basal Cell Carcinoma Syndrome (Gorlin-Goltz)
- Diagnostic criteria: first BCC <20 years, palmar pits, jaw cysts, calcified falx, medulloblastoma, first-degree relative with the syndrome (major criteria).
Clinical features
Clinical Presentation
- Lesions: Skin-colored or red or reddish-brown papules, plaques, nodules, or ulcers.
- Typical: pearled border and telangiectasias.
- Further signs: Surface sheen, bizarre tumor vessels.
Dermoscopy of BCC
- Vascular criterion: arborizing (tree-like branching) telangiectasias — bold, sharply focused vessels branching dichotomously on the tumour surface. Superficial BCC instead shows short, fine telangiectasias.
- Pigment criteria (especially pigmented BCC): blue-grey ovoid nests (large, sharply demarcated pigment aggregates), multiple blue-grey globules, maple-leaf-like areas at the periphery, spoke-wheel areas and concentric structures.
- Further signs: ulceration or multiple small erosions, and shiny white blotches and strands (visible only under polarized light).
- Note: spoke-wheel areas and arborizing vessels are highly specific; the absent pigment network separates pigmented BCC from melanoma.
Clinical Subtypes
- Nodular BCC: most common type; pearly papule with telangiectasias, usually face.
- Superficial BCC: erythematous, sharply demarcated plaque, usually trunk.
- Sclerodermiform (morpheaform) BCC: scar-like, infiltrative, ill-defined margin, high recurrence risk.
- Pigmented BCC: darkly pigmented; DD: melanoma.
- Infiltrative BCC: aggressive growth, ill-defined border.
- Micronodular BCC: small tumor nests, aggressive.
- Fibroepithelioma of Pinkus: lumbosacral, skin-colored papule, BCC variant with low recurrence risk.
- Basosquamous carcinoma: mixed BCC + SCC features, higher metastatic potential.
Differential diagnoses
Keratoacanthoma
Dermatofibroma
Melanoma
Trichoepithelioma
Actinic keratosis
Seborrhoeic keratosis
Cutaneous squamous cell carcinoma
Sebaceous hyperplasia
Image credits for the thumbnails
- Keratoacanthoma: Klaus D. Peter, Wiehl, Germany, “Spinaliom”, CC BY 3.0 DE, via Wikimedia Commons · CC BY 3.0 DE · Source
- Dermatofibroma: Jmarchn, “Pigmented and tenderness dermatofibroma”, CC BY-SA 3.0, via Wikimedia Commons · CC BY-SA 3.0 · Source
- Melanoma: National Cancer Institute (unknown photographer), “Melanoma (4)”, Public Domain, via Wikimedia Commons · Public domain · Source
- Trichoepithelioma: Klaus D. Peter, Wiehl, Germany, “Trichoepithelioma”, CC BY 3.0 de, via Wikimedia Commons · CC BY 3.0 de · Source
- Actinic keratosis: Future FamDoc, “Actinic keratosis on ear”, CC BY-SA 4.0, via Wikimedia Commons · CC BY-SA 4.0 · Source
- Seborrhoeic keratosis: Assafn, “Seborrheic keratosis closup”, CC BY-SA 4.0, via Wikimedia Commons · CC BY-SA 4.0 · Source
- Cutaneous squamous cell carcinoma: Klaus D. Peter, Wiehl, Germany, “Spinaliom3”, CC BY 3.0 DE, via Wikimedia Commons · CC BY 3.0 DE · Source
- Sebaceous hyperplasia: Klaus D. Peter, Wiehl, “Seborrhoeic dermatitis2” (Commons label differs from the diagnosis), CC BY 3.0 DE, via Wikimedia Commons · CC BY 3.0 DE · Source
Treatment principles
- The standard is surgical removal with histological margin control, as micrographically controlled surgery for ill-defined tumours, high-risk sites or recurrences.
- For superficial basal cell carcinoma, topical treatments, photodynamic therapy or cryotherapy are also options, and radiotherapy for inoperable tumours.
- Locally advanced or metastatic tumours are discussed by the tumour board and can be treated with hedgehog pathway inhibitors and, after failure or intolerance, with immune checkpoint inhibitors.
Guideline: AWMF guideline register (no. 032-021OL)
Specific treatment regimens with drugs and doses are covered in the DermaFuchs app.
Keep learning in the app
References (selection)
Cross-references
Mentioned in
Keep learning: test yourself
Two questions from the DermaFuchs app on Basal cell carcinoma – tap an answer.
Question 1 of 2
Which histological subtypes of basal cell carcinoma are considered high-risk features?
Answer
Correct: sclerodermiform, infiltrative, metatypic, micronodular. Sclerodermiform, infiltrative, metatypic, and micronodular subtypes of BCC exhibit aggressive growth patterns and a higher risk of recurrence.
Question 2 of 2
Which combination of clinical findings is characteristic of Gorlin-Goltz syndrome (nevoid basal cell carcinoma syndrome)?
Answer
Correct: multiple BCCs <30 years, palmar pits, jaw cysts. Gorlin-Goltz syndrome is characterized by multiple early-onset BCCs, palmar pits, and odontogenic keratocysts of the jaw.
More questions like these – with explanations and spaced repetition – in the app.
Note: This page is intended for medical education and does not replace diagnosis or treatment decisions in individual cases.